ETFs positioned on Masimo Corporation

Name YTD change Weight AuM
+12.13%-.--% 67 M€
+1.83%-.--% 51 M€
+11.90%-.--% 28 M€
+19.41%-.--% 2,959 M€
+2.58%5.51% 31 M€
+7.73%4.45% 15 M€
+19.03%3.9% 4 M€
+14.86%3.82% 0 M€
+16.05%2.93% 6 M€
+19.17%2.55% 10 M€
+8.37%2.33% 176 M€
+20.84%1.69% 303 M€
+14.30%1.36% 794 M€
+18.24%1.23% 362 M€
+8.19%1.22% 56 M€
+13.27%0.83% 7,651 M€
-.--%0.81% 2 M€
-11.79%0.72% 3,478 M€
+32.08%0.58% 42 M€
+19.84%0.49% 1,713 M€
-13.81%0.48% 234 M€
+19.43%0.47% 11,225 M€
+33.15%0.45% 23 M€
+7.76%0.43% 3 M€
+16.00%0.42% 34 M€
+9.94%0.41% 61 M€
+17.40%0.3% 135 M€
+26.26%0.29% 195 M€
+12.88%0.27% 7 M€
+21.64%0.26% 116 M€
+16.19%0.25% 29 M€
+15.80%0.23% 2,826 M€
+16.05%0.23% 3,947 M€
+18.79%0.23% 24,702 M€
+15.66%0.23% 406 M€
+16.20%0.23% 127,745 M€
Logo Masimo Corporation
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Employees
2,200
  1. Stock Market
  2. Stocks
  3. MASI Stock
  4. ETFs Masimo Corporation